NCT04637009 2024-08-02A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsAstex Pharmaceuticals, Inc.Phase 1 Terminated20 enrolled
NCT00020969 2020-10-05Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesCTI BioPharmaPhase 2 Terminated
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts